Enzyre is a UMC St. Radboud spin-off company which officially started in March 2017. It was founded with the mission to develop innovative diagnostic solutions to enable personalized medicine. The company holds the vision to create a point of care (POC) diagnostic platform that will measure a multitude of enzymatic reactions based on chemiluminescence.
Location: Netherlands, Gelderland, Nijmegen
Employees: 11-50
Total raised: $13.53M
Founded date: 2016
Investors 2
| Date | Name | Website |
| - | Novalis Bi... | noval.is |
| 06.02.2022 | Takeda Ven... | takeda.com |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 04.11.2022 | Series A | $11.88M | - |
| 27.07.2020 | - | $1.65M | - |
Mentions in press and media 8
| Date | Title | Description |
| 04.11.2022 | Enzyre closes Series A financing round of EUR 12M to advance pioneering diagnostic technology platform for hemophilia patients | |
| 04.11.2022 | i&i Biotech Fund investoval více než 1 milion eur do unikátní diagnostické technologie pro testování srážlivosti krve | Firma Enzyre je šestou společností, kterou pomohl fond i&i Biotech Fund od svého založení v srpnu 2021 svými investicemi podpořit. Více na www.inibio.eu. Jsme nadšeni, že můžeme společnost Enzyre doprovázet při vývoji tak slibné inovati... |
| 03.11.2022 | Dutch-based Enzyre bags €12.2M to develop diagnostic device for haemophilia patients | Nijmegen, the Netherlands-based Enzyre, a Radboud University Medical Center spin-out, announced on Wednesday, November 2, that it has secured $12M (approximately €12.2M) in a Series A round of funding. The round was led by new investor Oost... |
| 03.11.2022 | Netherlands-based diagnostic technology platform startup Enzyre raises EUR 12 million in Series A funding | NIJMEGEN, the Netherlands, November 2, 2022 — Enzyre, which is developing ground-breaking ambulant diagnostic technology for blood coagulation testing, announced today that it had raised EUR 12 million in a Series A financing led by new inv... |
| 02.11.2022 | Enzyre Closes EUR12M Series A Financing | Enzyre, a Nijmegen, Netherlands-based provider of ambulant diagnostic technology for blood coagulation testing, raised €12M in Series A funding. The round was led by Oost NL, with participation from i&i Biotech Fund, Demcon Investment, ... |
| 28.07.2020 | This Dutch startup is developing Enzypad to bring the lab to haemophilia patients, bags €1.4M funding | Based out of Nijmegen, The Netherlands, Enzyre is a spin-out from Radboud University Medical Center, developing Enzypad, a near-patient diagnostic and monitoring device initially focused on blood coagulation. Raised €1.4M Corona Bridge Loan... |
| 27.07.2020 | Enzyre Receives €1.4M Corona Bridge Loan | Enzyre, a Nijmegen, The Netherlands-based developer of diagnostic technology, received a €1.4m Corona Bridge Loan. Novalis Biotechnology Incubation, through its seed fund, participated as co-financer in the loan, which was granted by the Du... |
| - | Enzyre | “Enzyre - Near Patient Diagnostics Focused on Blood Coagulation” |